OTHER FUNCTIONS: SBIR PHASE I, "MED. ADHERENCE IN HIGHER RISK POPULATIONS," N43D

Ai Cure Technologies, Llc, New York NY

Investigators

Abstract

AI Cure Technologies seeks to develop and test the effectiveness and usability of AiView-HR, an automated, population-based medication adherence monitoring system for high-risk, substance abuse populations. AiView-HR will be a significant extension of Ai Cure Technologies' flagship computer-vision product, AiView, incorporating enhanced security sequence elements that will be critical to deploying automated DOT (directly observed therapy) to the high-risk, substance abuse population. Like AiView, AiView-HR will be coupled with a robust web-based dashboard that enables efficient population-based or individual monitoring, review, and intervention of medication adherence.